Expression of human α<sub>I</sub>-proteinase inhibitor in Aspergillus niger.
- Published in:
- Microbial Cell Factories, 2007, v. 6, p. 34, doi. 10.1186/1475-2859-6-34
- By:
- Publication type:
- Article
Works by Ophir, Yakir
Results: 8
1
2
Production of human α<sub>1</sub> proteinase inhibitor from Aspergillus niger.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
3
Development and Validation of an Innovative Analytical Approach for the Quantitation of Tris(Hydroxymethyl)Aminomethane (TRIS) in Pharmaceutical Formulations by Liquid Chromatography Tandem Mass Spectrometry.
- Published in:
- Molecules, 2023, v. 28, n. 1, p. 73, doi. 10.3390/molecules28010073
- By:
- Publication type:
- Article
4
Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform.
- Published in:
- Toxicologic Pathology, 2022, v. 50, n. 3, p. 294, doi. 10.1177/01926233221090518
- By:
- Publication type:
- Article
5
Versatile catechol dioxygenases in Sphingobium scionense WP01<sup>T</sup>.
- Published in:
- Antonie van Leeuwenhoek, 2018, v. 111, n. 12, p. 2293, doi. 10.1007/s10482-018-1120-y
- By:
- Publication type:
- Article
6
Production, purification, and characterization of human α1 proteinase inhibitor from Aspergillus niger.
- Published in:
- Biotechnology & Bioengineering, 2009, v. 102, n. 3, p. 828, doi. 10.1002/bit.22099
- By:
- Publication type:
- Article
7
Leveraging Walnut Somatic Embryos as a Biomanufacturing Platform for Recombinant Proteins and Metabolites.
- Published in:
- BioTech, 2024, v. 13, n. 4, p. 50, doi. 10.3390/biotech13040050
- By:
- Publication type:
- Article
8
Development and Validation of a Plaque Assay to Determine the Titer of a Recombinant Live-Attenuated Viral Vaccine for SARS-CoV-2.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 374, doi. 10.3390/vaccines12040374
- By:
- Publication type:
- Article